Back

Informing metastatic colorectal cancer patients by quantifying multiple scenarios

There is the wide belief, based on trial data that median overall survival of metastatic colorectal cancer patients receiving systemic therapy has improved substantially in the last decade. However, improvement could not be demonstrated in our real‐life population. Therefore, when informing patients about their life expectancy, clinicians should consider quoting multiple survival scenarios based on real‐life data instead of the median overall survival from clinical trials.

"Informing metastatic colorectal cancer patients by quantifying multiple scenarios for survival time based on real‐life data".

Publication in the International Journal of Cancer by a.o. Patricia Hamers (UMC Utrecht) and Geraldine Vink (UMC Utrecht/IKNL)

read the article here

Working at UMC Utrecht

Contact

Emergency?

Directions

Appointments

Practical

umcutrecht.nl maakt gebruik van cookies

Deze website maakt gebruik van cookies Deze website toont video’s van o.a. YouTube. Dergelijke partijen plaatsen cookies (third party cookies). Als u deze cookies niet wilt kunt u dat hier aangeven. Wij plaatsen zelf ook cookies om onze site te verbeteren.

Lees meer over het cookiebeleid

Akkoord Nee, liever niet